Patel Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 30-12-2024
- Paid Up Capital ₹ 2.20 Cr
as on 30-12-2024
- Company Age 31 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.96 Cr
as on 30-12-2024
- Satisfied Charges ₹ 1.15 Cr
as on 30-12-2024
- Revenue 35.44%
(FY 2022)
- Profit 36.86%
(FY 2022)
- Ebitda 28.97%
(FY 2022)
- Net Worth 3.49%
(FY 2022)
- Total Assets 15.94%
(FY 2022)
About Patel Remedies
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.20 Cr.
The company currently has active open charges totaling ₹11.96 Cr. The company has closed loans amounting to ₹1.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pareshkumar Vadalia, Maulikkumar Bhuva, and Milankumar Bhuva serve as directors at the Company.
- CIN/LLPIN
U24231GJ1993PTC020284
- Company No.
020284
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationJunagadh, Gujarat
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Patel Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pareshkumar Vadalia  | Director | 27-Sep-1993 | Current |
| Maulikkumar Bhuva | Director | 01-Apr-2019 | Current |
| Milankumar Bhuva | Director | 01-Apr-2010 | Current |
Financial Performance of Patel Remedies.
Patel Remedies Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 35.44% increase. The company also saw a substantial improvement in profitability, with a 36.86% increase in profit. The company's net worth moved up by a moderate rise of 3.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Patel Remedies?
In 2021, Patel Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Mar 2008 | ₹5.98 Cr | Open |
Others Creation Date: 03 Mar 2008 | ₹5.98 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 27 Dec 2010 | ₹2.50 M | Satisfied |
How Many Employees Work at Patel Remedies?
Unlock and access historical data on people associated with Patel Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Patel Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Patel Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
